2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theSolid Tumor Testing Market?

The solid tumor testing market is set to expand due to a rise in cancer cases. Cancer is characterized by the unusual growth and proliferation of cells in the body. These deviant cells, otherwise known as cancer cells, have the ability to attack nearby tissues and organs. They can also circulate to other body parts via the bloodstream or lymph system. Solid tumors make up approximately 90% of cancers in adults. Solid tumor testing identifies cancer cells in the patient’s blood, even if the cancer hasn’t appeared on imaging tests yet. For example, the Centers for Disease Control and Prevention, a national public health agency in the US, disclosed in June 2023 that in 2020 there were 1,603,844 newly diagnosed cancer cases and 602,347 deaths related to cancer. There were 403 new cancer cases and 144 cancer-related fatalities per 100,000 individuals. Hence, a surge in cancer cases is propelling the development of the solid tumor testing market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12658&type=smp

#How Will the CAGR of the Solid Tumor Testing Market Influence Its Overall Growth by 2034?

The market size for solid tumor testing has experienced significant expansion in the past few years. It is projected to increase from $27.96 billion in 2024 to $30 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. This surge in the historical period is due to factors such as personalized or precision medicine, poor selective drug delivery for tumors, low efficacy of therapeutic methods, unaffordable expenses, and simplified approaches towards cancer chemotherapies.

The market of solid tumor testing is projected to experience significant expansion in the coming years. By 2029, it’s predicted to reach a value of $40.06 billion, growing at a compound annual growth rate (CAGR) of 7.5%. This growth during the projected period is likely due to several factors including the rising incidence of cancer, improvements in healthcare infrastructure, the introduction of AI and IoT-enabled diagnostic devices, and increased government initiatives. Key trends to look out for during this forecast period include the development of new diagnostic tools, the implementation of nanocarrier-based therapies, strategic partnerships, and the introduction of next-generation testing devices.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12658

What Are the Current Market Growth and Trends in theSolid Tumor Testing Market That Industry Players Should Watch?

The rising trend of inventive liquid biopsy test solutions in the solid tumor testing market is gaining traction. Numerous major companies in the solid tumor testing market are now concentrating on creating novel liquid biopsy test solutions with the aim to solidify their market position and edge over their competitors. NeoGenomics Inc., a US-based laboratory testing firm, for example, initiated a complete range of three solid tumor liquid biopsy tests for cancer patients in June 2020. These cutting-edge tests are developed to identify cancer cells within the patient’s blood suffering from solid tumors even when the cancer remains undetectable in imaging tests. These tests assist medical practitioners in deciding the future course of testing or treatment. These are also non-invasive, facilitate early detection, can personalize the treatment, and have FDA approval. These three new tests also offer results in seven days or less, saving valuable time for clinicians.

What Are the Major Market Players Making an Impact on theSolid Tumor Testing Market Growth?

Major companies operating in the solid tumor testing market include Johnson & Johnson Ltd, Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Molecular Inc., Becton Dickinson And Company (BD), Quest Diagnostics Incorporated, Tosoh Corporation, Agilent Technologies Inc., bioMerieux Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN GmbH, Miltenyi Biotec GmbH, Natera Inc., Myriad Genetics Inc., Novocure Inc., Invitae Corporation, Guardant Health Inc., Foundation Medicine Inc., Epic Sciences Inc., Biocare Medical LLC, Agena Bioscience Inc., Caris Life Sciences Inc., 20/20 Gene Systems Inc., Grail Inc., Avant Diagnostics Inc., Genomic Testing Cooperative, Eutropics Pharmaceuticals Inc., Anixa Biosciences Inc., Cellular Biomedicine Group.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/solid-tumor-testing-global-market-report

How Are the Key Segments of the Solid Tumor Testing Market Driving Opportunities and Innovations?

The solid tumor testing market covered in this report is segmented –

1) By Type: Genetic Testing, Conventional Testing

2) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer

3) By Application: Clinical, Research

4) By End-Users: Hospitals, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic Research Institutions

Subsegments:

1) By Genetic Testing: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In Situ Hybridization (FISH)

2) By Conventional Testing: Histopathology, Cytology, Imaging Techniques

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12658&type=smp

What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theSolid Tumor Testing Market?# Market Expansion?

North America was the largest region in the solid tumor testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the solid tumor testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal Solid Tumor Testing Maret 2025, By The Business Research Company:

Solid State Relay Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/solid-state-relay-global-market-report

Tumor Infiltrating Lymphocytes Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/tumor-infiltrating-lymphocytes-global-market-report

Tumor Embolization Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: